Home Newsfeeds Kinnate Biopharma Q2 EPS $(0.62) Down From $(0.49) YoY

Kinnate Biopharma Q2 EPS $(0.62) Down From $(0.49) YoY

Kinnate Biopharma (NASDAQ:KNTE) reported quarterly losses of $(0.62) per share. This is a 26.53 percent decrease over losses of $(0.49) per share from the same period last year.

byBenzinga Newsdesk

August 11, 2022

1 minute read

Kinnate Biopharma (NASDAQ:KNTE) reported quarterly losses of $(0.62) per share. This is a 26.53 percent decrease over losses of $(0.49) per share from the same period last year.

Adicet Bio Stock Is Falling Premarket – Here’s Why

By Vandana Singh

June 27, 7:49 AM

Adicet Bio Inc (NASDAQ: ACET) shared safety and efficacy data from its Phase 1 study of ADI-001 for relapsed or refractory aggressive B-cell

ACET

News
Tech

Microsoft Rattles OpenAI With New AI Model That’s ‘As Capable As’ GPT-3.5, While Apple Is Still Hashing Out Its Google Gemini Plans For iPhones

By Rounak Jain

April 23, 6:07 AM

Microsoft's Phi-3 Mini is a new compact AI model designed to run on smartphones and laptops that is "as capable as" OpenAI's GPT-3.5.

MSFT

Here’s Why WiSA Technologies Stock Is Getting Hammered

By Henry Khederian

March 28, 12:40 PM

WiSA Technologies Inc (NASDAQ: WISA) shares are trading lower by 38.89% to $2.20 Tuesday afternoon after the company announced a registered direct offering of 837,209 shares at $1.91 per share. What Else?

WISA